Why invest in UBS All China Fund?
1. Captures high-growth sectors in domestic and offshore markets
Our all China equities approach provides you access to fast growing companies, no matter where they are listed
Domestic A share market
Larger exposure to consumption and healthcare companies
Eg. leading domestic brands in home appliances, liquor companies and traditional Chinese medicine
Offshore stocks (i.e. listed outside of China)
Innovative service companies in finance, tech, education, e-commerce sectors
2. High conviction, best ideas investments
The UBS All China Fund has 20-50 high conviction ideas in companies with strong long-term potential.
High conviction idea – Kweichou Moutai
#1 baijiu (white liquor) brand in China
Fund vs Benchmark allocation
5.7% vs 2.4%
References to securities are not buy or sell recommendations.
Source: UBS Asset Management, data as of 31 May 2020
- Kweichou Moutai is the most expensive baijiu in China (~S$ 240 for 0.375l)
- The grain and water used must originate from Moutai town
- In China, total Baijiu volume is growing at only 1%. But ultra premium baijiu brands like Kweichou Moutai is expected to increase by 15% yearly*
* Source: Bernstein, as of April 2018. Estimated volume growth (compounded) 2016 - 2000
Speak to distribution partners to learn more
- Standard Chartered Bank
- UBS Wealth Management
Get the latest UBS All China fund factsheet here.
It’s a matter of time
Bin says before China equities become a separate asset class like US or Japan equities.
And that’s why investors may want to start thinking about a dedicated allocation to China.
Perspectives matter. Tune in to our insights.
This advertisement or publication has not been reviewed by the Monetary Authority of Singapore.
UBS (Lux) Equity SICAV Fund (the “Fund”) is a Luxembourg open-ended investment fund. UBS Fund Management (Luxembourg) S.A. is the responsible person for the Fund and the Fund’s sub-fund, UBS (Lux) Equity SICAV – All China (USD) (the “Sub-Fund”) recognised under Section 287 of the Securities and Futures Act of Singapore. UBS Asset Management (Singapore) Ltd (Company Registration No.:199308367C) has been appointed as the Singapore representative (“UBS AM SG”).
Investors should read the Singapore prospectus (“Prospectus”) for further details before deciding to subscribe for or purchase units in the Sub-Fund, a copy of which can be downloaded from our website. The Prospectus can also be obtained free of charge from UBS AM SG, or from any of our authorized distributors as listed in our website. The price of the units in the Sub-Fund and the income accruing to those units, if any, may fall as well as rise. The Sub-Fund may [use or] invest in financial derivative instruments* to the extent permitted under Luxembourg laws. Due to the investment policies [and/or portfolio management techniques] of the Sub-Fund, it may experience greater volatility in its net asset value*. Investments in the Sub-Fund are not deposits in, obligations of, or guaranteed or insured by UBS AM SG, UBS AG, UBS Asset Management or any of their subsidiaries, associates or affiliates or distributors of the Sub-Fund and are subject to investment risks, including the possible loss of the principal amount investment. Past performance of the Sub-Fund, the management company and the portfolio manager and any past performance, prediction, projection, forecasts or information on the economic trends or securities market are not necessarily indicative of the future or likely performance of the Sub-Fund or the management company or the portfolio manager or a guarantee of future trends. [Any extraordinary performance may be due to exceptional circumstances which may not be sustainable.] No responsibility can be accepted by the management company or the portfolio manager to anyone for any action taken on the basis of the analysis. No representation or promise as to the performance of the funds or the return on your investment is made. Units of the Sub-Fund are not available to U.S. persons.
The information about the Sub-Fund provided in this document does not constitute an offer or solicitation to deal in units of the Sub-Fund or investment advice or recommendation. It is for informational purposes only. This document was prepared without regard to the specific investment objective(s), financial situation or the particular needs of any person. It is based on certain assumptions, information and conditions available as at the relevant date(s) and may be subject to change at any time without notice. Nothing in this document should be construed as advice or a recommendation to buy or sell units in the Sub-Fund. Investors may wish to seek independent advice from a financial adviser before making a commitment to invest in the Sub-Fund). In the event an investor chooses not to seek advice from a financial adviser, the investor should consider whether the Sub-Fund is suitable for him. © UBS 2020. The key symbol and UBS are among the registered and unregistered trademarks of UBS. All rights reserved.
*Please refer to the Prospectus for more information on the risks associated with investments in financial derivative instruments and the Sub-Fund’s volatility.